Jane Street Group, LLC Anavex Life Sciences Corp. Transaction History

Jane Street Group, LLC

  • $88.2 Billion
  • Q2 2024

A detailed history of Jane Street Group, LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Jane Street Group, LLC holds 181,946 shares of AVXL stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
181,946
Previous 44,900 305.22%
Holding current value
$1.03 Million
Previous $228,000 236.4%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$3.39 - $5.02 $464,585 - $687,970
137,046 Added 305.22%
181,946 $767,000
Q1 2024

May 15, 2024
SELL
$4.55 - $6.75 $306,715 - $455,017
-67,410 Reduced 60.02%
44,900 $228,000
Q4 2023

Feb 14, 2024
BUY
$5.04 - $9.95 $151,497 - $299,087
30,059 Added 36.55%
112,310 $1.05 Million
Q3 2023

Nov 14, 2023
SELL
$6.55 - $9.37 $2.31 Million - $3.3 Million
-352,041 Reduced 81.06%
82,251 $538,000
Q2 2023

Aug 14, 2023
BUY
$7.66 - $9.5 $3.17 Million - $3.93 Million
413,231 Added 1962.07%
434,292 $3.53 Million
Q1 2023

May 15, 2023
BUY
$8.32 - $11.75 $60,677 - $85,692
7,293 Added 52.97%
21,061 $180,000
Q4 2022

Feb 14, 2023
SELL
$7.65 - $14.43 $63,892 - $120,519
-8,352 Reduced 37.76%
13,768 $127,000
Q3 2022

Nov 14, 2022
BUY
$8.9 - $12.86 $27,794 - $40,161
3,123 Added 16.44%
22,120 $228,000
Q3 2022

Nov 14, 2022
BUY
$8.9 - $12.86 $27,794 - $40,161
3,123 Added 16.44%
22,120 $228,000
Q2 2022

Aug 16, 2022
SELL
$7.31 - $12.84 $532,211 - $934,829
-72,806 Reduced 79.31%
18,997 $190,000
Q1 2022

May 17, 2022
SELL
$9.74 - $17.69 $587,643 - $1.07 Million
-60,333 Reduced 39.66%
91,803 $1.13 Million
Q4 2021

Feb 15, 2022
SELL
$16.88 - $23.31 $876,966 - $1.21 Million
-51,953 Reduced 25.46%
152,136 $2.64 Million
Q3 2021

Nov 16, 2021
SELL
$16.82 - $25.75 $22,892 - $35,045
-1,361 Reduced 0.66%
204,089 $3.66 Million
Q2 2021

Aug 16, 2021
BUY
$10.16 - $28.86 $1.27 Million - $3.61 Million
124,941 Added 155.19%
205,450 $4.7 Million
Q1 2021

May 18, 2021
BUY
$5.17 - $16.13 $362,303 - $1.13 Million
70,078 Added 671.82%
80,509 $1.2 Million
Q4 2020

Feb 17, 2021
SELL
$4.01 - $7.58 $174,884 - $330,578
-43,612 Reduced 80.7%
10,431 $57,000
Q3 2020

Nov 17, 2020
BUY
$3.8 - $5.0 $205,363 - $270,215
54,043 New
54,043 $246,000
Q3 2019

Nov 14, 2019
SELL
$2.22 - $3.9 $316,014 - $555,161
-142,349 Closed
0 $0
Q2 2019

Aug 15, 2019
BUY
$2.75 - $3.7 $356,600 - $479,790
129,673 Added 1022.98%
142,349 $480,000
Q1 2019

May 16, 2019
BUY
$1.68 - $3.42 $21,295 - $43,351
12,676 New
12,676 $39,000
Q3 2018

Nov 14, 2018
SELL
$2.23 - $3.82 $133,365 - $228,455
-59,805 Closed
0 $0
Q2 2018

Aug 15, 2018
BUY
$2.08 - $4.26 $124,394 - $254,769
59,805 New
59,805 $157,000

Others Institutions Holding AVXL

# of Institutions
152
Shares Held
26.5M
Call Options Held
674K
Put Options Held
811K
View Full List

About ANAVEX LIFE SCIENCES CORP.

AVXL Quotes by TradingView
  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $443M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email